215 related articles for article (PubMed ID: 38037913)
21. Curcuminoids in neurodegenerative diseases.
Kim DS; Kim JY; Han Y
Recent Pat CNS Drug Discov; 2012 Dec; 7(3):184-204. PubMed ID: 22742420
[TBL] [Abstract][Full Text] [Related]
22. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
23. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
24. DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease.
Krishnan N; Felice C; Rivera K; Pappin DJ; Tonks NK
Genes Dev; 2018 Jul; 32(13-14):944-952. PubMed ID: 29945887
[TBL] [Abstract][Full Text] [Related]
25. Rebalancing metal dyshomeostasis for Alzheimer's disease therapy.
Yang GJ; Liu H; Ma DL; Leung CH
J Biol Inorg Chem; 2019 Dec; 24(8):1159-1170. PubMed ID: 31486954
[TBL] [Abstract][Full Text] [Related]
26. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
Wang Y; Lv MN; Zhao WJ
Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
[TBL] [Abstract][Full Text] [Related]
27. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
Maher P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
[TBL] [Abstract][Full Text] [Related]
28. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis.
Gil-Bea FJ; Aldanondo G; Lasa-Fernández H; López de Munain A; Vallejo-Illarramendi A
Expert Rev Mol Med; 2017 Jun; 19():e7. PubMed ID: 28597807
[TBL] [Abstract][Full Text] [Related]
29. Prochelator strategies for site-selective activation of metal chelators.
Oliveri V; Vecchio G
J Inorg Biochem; 2016 Sep; 162():31-43. PubMed ID: 27297691
[TBL] [Abstract][Full Text] [Related]
30. Metal homeostasis disturbances in neurodegenerative disorders, with special emphasis on Creutzfeldt-Jakob disease - Potential pathogenetic mechanism and therapeutic implications.
Nakagawa Y; Yamada S
Pharmacol Ther; 2020 Mar; 207():107455. PubMed ID: 31863817
[TBL] [Abstract][Full Text] [Related]
31. The role of copper in neurodegenerative disease.
Waggoner DJ; Bartnikas TB; Gitlin JD
Neurobiol Dis; 1999 Aug; 6(4):221-30. PubMed ID: 10448050
[TBL] [Abstract][Full Text] [Related]
32. The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron disease.
Bakkar N; Starr A; Rabichow BE; Lorenzini I; McEachin ZT; Kraft R; Chaung M; Macklin-Isquierdo S; Wingfield T; Carhart B; Zahler N; Chang WH; Bassell GJ; Betourne A; Boulis N; Alworth SV; Ichida JK; August PR; Zarnescu DC; Sattler R; Bowser R
Neurobiol Dis; 2021 Feb; 149():105228. PubMed ID: 33359139
[TBL] [Abstract][Full Text] [Related]
33. Radiocopper for the imaging of copper metabolism.
Hueting R
J Labelled Comp Radiopharm; 2014 Apr; 57(4):231-8. PubMed ID: 24634197
[TBL] [Abstract][Full Text] [Related]
34. Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development.
Grabska-Kobyłecka I; Szpakowski P; Król A; Książek-Winiarek D; Kobyłecki A; Głąbiński A; Nowak D
Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571391
[TBL] [Abstract][Full Text] [Related]
35. Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Tokuda E; Furukawa Y
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136532
[TBL] [Abstract][Full Text] [Related]
36. Iron chelation and neuroprotection in neurodegenerative diseases.
Li X; Jankovic J; Le W
J Neural Transm (Vienna); 2011 Mar; 118(3):473-7. PubMed ID: 21161300
[TBL] [Abstract][Full Text] [Related]
37. Targeting BDNF signaling by natural products: Novel synaptic repair therapeutics for neurodegeneration and behavior disorders.
Bawari S; Tewari D; Argüelles S; Sah AN; Nabavi SF; Xu S; Vacca RA; Nabavi SM; Shirooie S
Pharmacol Res; 2019 Oct; 148():104458. PubMed ID: 31546015
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges.
Han J; Chitu V; Stanley ER; Wszolek ZK; Karrenbauer VD; Harris RA
Cell Mol Life Sci; 2022 Apr; 79(4):219. PubMed ID: 35366105
[TBL] [Abstract][Full Text] [Related]
39. Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities.
Yan L; Guo MS; Zhang Y; Yu L; Wu JM; Tang Y; Ai W; Zhu FD; Law BY; Chen Q; Yu CL; Wong VK; Li H; Li M; Zhou XG; Qin DL; Wu AG
Oxid Med Cell Longev; 2022; 2022():5288698. PubMed ID: 35237381
[TBL] [Abstract][Full Text] [Related]
40. Flavonoids targeting NRF2 in neurodegenerative disorders.
Khan H; Tundis R; Ullah H; Aschner M; Belwal T; Mirzaei H; Akkol EK
Food Chem Toxicol; 2020 Dec; 146():111817. PubMed ID: 33069760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
